• 2-NBDG Workflows for Cellular Glucose Uptake

  2026-09-07

  Build a quantitative glucose uptake workflow around 2-NBDG, from fresh aqueous stock preparation to flow cytometry, microscopy, and plate-based analysis. The approach translates recent gestational diabetes findings into practical functional assays while addressing cell-type-specific kinetics, self-quenching, and normalization.

• Trolox Workflows for Oxidative Stress Assays

  2026-09-05

  Trolox provides a reproducible redox benchmark for cell protection studies, antioxidant capacity measurements, and high-throughput screening. This practical guide shows how to prepare, apply, and troubleshoot Trolox while translating findings from microalgal antioxidant research into assay-ready decisions.

• Bestatin-Derived Inhibitors of IRAP and ERAP1

  2026-09-05

  The reference study develops a stereochemically controlled route for functionalizing Bestatin’s α-hydroxy-β-amino acid scaffold and applies it to selective inhibition of IRAP, ERAP1, and ERAP2. Structural and cellular data identify P1 side-chain engineering and interactions with the IRAP GAMEN loop as important determinants of potency and selectivity, including a cell-active IRAP inhibitor with low-nanomolar activity.

• Trolox Workflows for Oxidative Stress Assays

  2026-09-04

  Trolox provides a practical, cell-permeable antioxidant benchmark for connecting biochemical scavenging measurements with cell-based oxidative injury models. This guide combines formulation, treatment, lipid peroxidation readouts, ferroptosis-aware controls, and troubleshooting for reproducible antioxidant experiments.

• Verapamil Targets Txnip in Osteoporosis

  2026-09-04

  This study links TXNIP genetic variation and verapamil-mediated TXNIP suppression to bone remodeling, combining human association data with osteoclast, osteoblast, and ovariectomized-mouse experiments. Its main translational contribution is a mechanistic rationale for investigating verapamil as a Txnip-directed strategy in postmenopausal osteoporosis, while retaining important preclinical limitations.

• 2'3'-cGAMP: A Calibrator for NAD-Stress STING Assays

  2026-09-03

  Discover how 2'3'-cGAMP (sodium salt) can calibrate cGAS-STING signaling pathway assays during chronic NAD depletion. This article translates mitochondrial DNA leakage findings into practical controls for studying type I interferon induction and STING competence.

• Standardized Whole-Blood Stimulation in Immunometabolism

  2026-09-03

  Zhao and colleagues present a standardized whole-blood stimulation protocol that combines immune challenges with targeted metabolic perturbation and cytokine quantification. The approach preserves the multicellular blood environment while enabling cohort-scale analysis of how anabolic and catabolic pathways shape immune responses.

• G418 Sulfate (Geneticin): Mechanism & Selection

  2026-09-02

  G418 Sulfate, also called Geneticin, is an aminoglycoside antibiotic used to inhibit translation and select mammalian cells carrying a neomycin-resistance gene. Product data also report antiviral activity against Dengue virus serotype 2 in BHK cells, while emphasizing that concentration, cell type, and assay conditions determine performance.

• 3-Aminobenzamide: PARP Assay Workflows

  2026-09-02

  Build reproducible PARP perturbation assays with 3-Aminobenzamide (PARP-IN-1), from oxidative-stress models to endothelial and renal endpoints. The workflow emphasizes dose-finding, target-engagement controls, and careful translation of antiviral findings without overstating what the reference study proves.

• Dorsomorphin (Compound C): AMPK Workflow Guide

  2026-09-01

  Build more informative AMPK, BMP, autophagy, and differentiation experiments with a reversible ATP-competitive inhibitor. This workflow guide connects time-resolved stress biology from rotavirus research with practical dosing, controls, and troubleshooting for Dorsomorphin (Compound C).

• CLK2, BRCA1, and Platinum Resistance in Ovarian Cancer

  2026-08-31

  The reference study identifies CLK2 as a driver of platinum resistance in ovarian cancer and links this phenotype to CLK2-dependent phosphorylation of BRCA1 at Ser1423, which enhances DNA damage repair. Its tissue, cellular, and xenograft evidence supports CLK2 as a mechanistically grounded research target, while also highlighting the need to distinguish CLK2-specific effects from broader kinase and splicing biology.

• ROS, PDKs, and Melanoma Growth After BRAF Inhibition

  2026-08-31

  Cesi et al. show that BRAF or MEK pathway inhibition increases reactive oxygen species, activates pyruvate dehydrogenase kinases, and suppresses PDH-dependent oxidative metabolism in melanoma cells. The study identifies PDK1 inhibition as a potentially useful strategy for targeting BRAF-mutant and BRAF-inhibitor-resistant cells, while also providing a framework for studying metabolic adaptation during targeted therapy.

• Selective IRAP Inhibitors from Bestatin

  2026-08-30

  The reference study introduces a stereocontrolled route to α-hydroxy-β-amino acid derivatives of bestatin and combines structural, biochemical, and cellular analyses to identify selective IRAP inhibitors. Its strongest result is a cell-active, low-nanomolar inhibitor with more than 120-fold selectivity over homologous aminopeptidases, while crystallography highlights the GAMEN loop as an important determinant of selectivity.

• Alda 1 Workflows for Cardiac ALDH2 Research

  2026-08-29

  Alda 1 is an ALDH2 activator for connecting aldehyde detoxification with cardiomyocyte proliferation, pressure-overload heart failure, and cardiac ischemia research. This guide translates its biochemical properties into practical assay workflows while distinguishing established preclinical findings from optimization starting points for new experiments.

• EGTA Workflows for Calcium Signaling Assays

  2026-08-29

  Use EGTA as a controlled calcium-removal tool to distinguish extracellular calcium dependence from receptor and channel-specific effects. This workflow connects patch-clamp experiments with neuroprotection, apoptosis assays, and carefully bounded extensions into endothelial inflammation research.

459 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page